119 related articles for article (PubMed ID: 6261941)
1. Regulation of cyclic adenosine 3',5'-monophosphate in relation to growth of dimethylbenz[a]anthracene-induced mammary tumors in rats.
Ip C; Dao TL
Cancer Lett; 1980 Jan; 8(3):227-33. PubMed ID: 6261941
[TBL] [Abstract][Full Text] [Related]
2. Relationship of adenosine 3',5'-cyclic monophosphate and guanosine 3',5'-cyclic monophosphate to growth of dimethylbenz(a)anthracene-induced mammary tumors in rats.
Matusik RJ; Hilf R
J Natl Cancer Inst; 1976 Mar; 56(3):659-61. PubMed ID: 176403
[TBL] [Abstract][Full Text] [Related]
3. Levels of cyclic nucleotides in autotransplanted 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors during their growth and regression.
Lee C
J Natl Cancer Inst; 1980 Nov; 65(5):1029-32. PubMed ID: 6253705
[TBL] [Abstract][Full Text] [Related]
4. Anticarcinogenic effect of N6,O2'-dibutyryl cyclic adenosine 3':5'-monophosphate on 7,12-dimethylbenz(a)anthracene mammary tumor induction in the rat and its relationship to cyclic adenosine 3':5'-monophosphate metabolism and protein kinase.
Cho-Chung YS; Clair T; Shepheard C
Cancer Res; 1983 Jun; 43(6):2736-40. PubMed ID: 6303567
[TBL] [Abstract][Full Text] [Related]
5. Inverse relation between estrogen receptors and cyclic adenosine 3':5'-monophosphate-binding proteins in hormone-dependent mammary tumor regression due to dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
Bodwin JS; Clair T; Cho-Chung YS
Cancer Res; 1978 Oct; 38(10):3410-3. PubMed ID: 210938
[TBL] [Abstract][Full Text] [Related]
6. Cyclic AMP-binding proteins: inverse relationship with estrogen-receptors in hormone-dependent mammary tumor regression.
Cho-Chung YS; Bodwin JS; Clair T
Eur J Biochem; 1978 May; 86(1):51-60. PubMed ID: 207518
[TBL] [Abstract][Full Text] [Related]
7. Concurrent changes in growth-related biochemical parameters during regression of hormone-dependent rat mammary tumors.
Foecking MK; Abou-Issa H; Webb TE; Minton JP
J Natl Cancer Inst; 1983 Oct; 71(4):773-8. PubMed ID: 6312151
[TBL] [Abstract][Full Text] [Related]
8. Regression of hormone-dependent mammary tumors in Sprague-Dawley rats as a result of tamoxifen or pharmacologic doses of 17 beta-estradiol: cyclic adenosine 3',5'-monophosphate-mediated events.
Bodwin JS; Hirayama PH; Rego JA; Cho-Chung YS
J Natl Cancer Inst; 1981 Feb; 66(2):321-6. PubMed ID: 6256577
[TBL] [Abstract][Full Text] [Related]
9. Striatal dopamine-stimulated adenylate cyclase activity reflects susceptibility of rats to 7,12-dimethylbenz[a]anthracene-induced mammary tumor development.
Goldman PR; Vogel WH
Carcinogenesis; 1984 Jul; 5(7):971-3. PubMed ID: 6428770
[TBL] [Abstract][Full Text] [Related]
10. Influence of hormonal alteration of host on estrogen-binding capacity in 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
Gibson SL; Hilf R
Cancer Res; 1976 Oct; 36(10):3736-41. PubMed ID: 133755
[TBL] [Abstract][Full Text] [Related]
11. Morphology, growth characteristics and oestrogen-binding capacity of DMBA-induced mammary tumours from ovariectomized rats.
Boylan ES; Fowler EH; Wittliff JL
Br J Cancer; 1977 May; 35(5):602-9. PubMed ID: 405032
[TBL] [Abstract][Full Text] [Related]
12. Antagonistic action between cyclic AMP and estrogen in phosphorylation of mammary tumor nuclear proteins.
Cho-chung YS; Doud FJ
Cancer Lett; 1978 Oct; 5(4):219-24. PubMed ID: 210929
[TBL] [Abstract][Full Text] [Related]
13. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors.
Tsai TL; Katzenellenbogen BS
Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032
[TBL] [Abstract][Full Text] [Related]
14. Activities and some properties of adenylate cyclase and phosphodiesterase in muscle, liver and nervous tissues from vertebrates and invertebrates in relation to the control of the concentration of adenosine 3':5'-cyclic monophosphate.
Arch JR; Newsholme EA
Biochem J; 1976 Sep; 158(3):603-22. PubMed ID: 186042
[TBL] [Abstract][Full Text] [Related]
15. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
[TBL] [Abstract][Full Text] [Related]
16. Cyclic nucleotides and their associated enzymes in 9,10-dimethyl-1,2-benzanthracene-induced mammary tumors of rats.
Rillema JA; Mulder JA; Anderson LD
Cancer Res; 1978 Mar; 38(3):741-4. PubMed ID: 23896
[No Abstract] [Full Text] [Related]
17. Regulation of estrogen-binding capacity by insulin in 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Gibson SL; Hilf R
Cancer Res; 1980 Jul; 40(7):2343-8. PubMed ID: 6770998
[TBL] [Abstract][Full Text] [Related]
18. Relationship between insulin and estrogen binding to growth response in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
Shafie SM; Hilf R
Cancer Res; 1978 Mar; 38(3):759-64. PubMed ID: 414834
[TBL] [Abstract][Full Text] [Related]
19. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
Klinge CM; Bambara RA; Zain S; Hilf R
Cancer Res; 1989 Mar; 49(5):1165-70. PubMed ID: 2492902
[TBL] [Abstract][Full Text] [Related]
20. Prolactin and estrogen dependency of rat mammary cancers at early and late stages of development.
Bradley CJ; Kledzik GS; Meites J
Cancer Res; 1976 Feb; 36(2 Pt 1):319-24. PubMed ID: 816459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
